<DOC>
	<DOCNO>NCT00619242</DOCNO>
	<brief_summary>To determine whether sorafenib able change pre-cancerous cell way believe important progression cancer .</brief_summary>
	<brief_title>The Effects Sorafenib Molecular Barrett 's Esophagus Cancer</brief_title>
	<detailed_description>To characterize effect sorafenib specific molecular marker patient Barrett 's esophagus high grade intraepithelial neoplasia ( HGIN ) carcinoma situ ( CIS ) .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>ECOG performance status 02 Life expectancy great 12 month No prior history esophageal surgery endoscopic treatment dysplasia No prior exposure sorafenib Patients may receive investigational agent concomitant antineoplastic therapy , exception androgen ablate agent ( patient prior prostate cancer ) Age 18 year . Patients must adequate organ marrow function define : hemoglobin : 8.5 g/dL absolute neutrophil count : 1,500/L platelet : 100,000/L ( great 35,000/L without transfusion le 1 X institutional upper limit normal ) creatinine le 1.5 X institutional upper limit normal Ability understand willingness sign write informed consent . A patient withdrawn study follow event occur therapy : Interruption schedule therapy great 7 day Intolerable adverse effect judge investigator either physically psychologically detrimental patient Patient decision discontinue treatment Pregnancy Patient noncompliance therapy administration Grade 3 4 NCICTC toxicity attributable sorafenib Treatment chemotherapeutic investigational antineoplastic drug Disease progression HIVpositive patient receive combination antiretroviral therapy exclude study possible pharmacokinetic interaction sorafenib.Appropriate study undertaken patient receive combination antiretroviral therapy indicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Esophageal cancer</keyword>
</DOC>